Timber Pharmaceuticals Stock Quote TMBR - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.3426

Bid

Ask

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

0.3426

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American

WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and...

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance

WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...

Timber Pharmaceuticals to be Acquired by LEO Pharma

Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value RightsTotal Transaction Value of up to $36 millionTransaction Expected to...

Timber Pharmaceuticals Discloses Communication From NYSE American

WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...

Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis

- First Presentation of Data From Phase 3 ASCEND Study Will Feature Pharmacokinetic Results That Indicate Minimal Systemic Absorption of Isotretinoin - - Data to be Presented at the Society for...

Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

- Phase 3 ASCEND study of TMB-001 (topical isotretinoin) for the treatment of congenital ichthyosis is 70% enrolled - WARREN, NJ, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber...

Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results

- Timber has now Enrolled Over 60% of Patients for Pivotal TMB-001 Phase 3 ASCEND Clinical Trial - WARREN, NJ, May 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc...

Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results

- Lead asset TMB-001 is only compound to receive official orphan drug designation from European Commission for two severe subtypes of congenital ichthyosis, ARCI and XLRI - - Timber has enrolled...

Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology

- Treatment with TMB-001 demonstrated greater proportions of participants achieving primary and key secondary endpoints versus vehicle regardless of the subtype of congenital ichthyosis - BASKING...

Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis

Company Progressing With Pivotal Phase 3 ASCEND Clinical Trial in the U.S., Canada, Italy, France, and Germany BASKING RIDGE, NJ, Feb. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

TMBR - Frequently Asked Questions (FAQ)

What is the current Timber Pharmaceuticals share price?

The current share price of Timber Pharmaceuticals is $ 0.3426

What is the 1 year trading range for Timber Pharmaceuticals share price?

Timber Pharmaceuticals has traded in the range of $ 0.00 to $ 0.00 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BBLUEa Bridgeway Blue Chip ETF	$ 18.00 (35.03%)	5
CTMCastellum Inc	$ 0.7059 (21.71%)	2.38M
BQBoqii Holding Limited	$ 0.3601 (19.99%)	363.31k
BBPVirtus LifeSci Biotech Products ETF	$ 72.00 (18.90%)	5
KNWKnow Labs Inc	$ 0.174 (10.13%)	34.61k
TOVXTheriva Biologics Inc	$ 1.54 (-12.50%)	59.37k
HTECRobo Global Healthcare Technology and Innovation ETF	$ 26.32 (-9.93%)	1
BGIBirks Group Inc	$ 1.46 (-9.57%)	25
ETHU2x Ether ETF	$ 7.88 (-9.48%)	3.69M
ETHTProshares Ultra Ether ETF	$ 21.98 (-9.36%)	76.09k
MSTUT Rex 2X Long MSTR Daily Target ETF	$ 11.09 (-6.49%)	3.75M
ETHU2x Ether ETF	$ 7.88 (-9.48%)	3.69M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 1.90 (-4.28%)	3.44M
SOXLDirexion Daily Semiconductor Bull 3X Shares	$ 29.84 (-2.10%)	3.05M
CTMCastellum Inc	$ 0.7059 (21.71%)	2.38M